Tower Research Capital LLC (TRC) - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2024$15,254
+100.1%
21,699
+170.4%
0.00%
Q1 2024$7,623
+11.6%
8,024
+30.4%
0.00%
Q4 2023$6,832
+352.5%
6,155
+666.5%
0.00%
Q3 2023$1,510
+188.2%
803
+450.0%
0.00%
Q2 2023$524
-47.6%
146
-84.8%
0.00%
Q3 2022$1,000
-95.5%
958
-86.0%
0.00%
Q1 2022$22,000
-84.9%
6,829
-80.5%
0.00%
-100.0%
Q4 2021$146,000
-36.8%
35,004
+23.0%
0.00%
-50.0%
Q3 2021$231,000
+6.0%
28,447
-1.1%
0.01%0.0%
Q2 2021$218,000
+459.0%
28,774
+542.6%
0.01%
+500.0%
Q1 2021$39,000
+8.3%
4,478
-2.4%
0.00%0.0%
Q4 2020$36,000
-87.9%
4,587
-87.7%
0.00%
-66.7%
Q3 2020$297,000
+350.0%
37,220
+460.0%
0.00%0.0%
Q2 2020$66,000
+340.0%
6,646
+67.3%
0.00%
+200.0%
Q4 2019$15,000
+36.4%
3,972
+75.3%
0.00%0.0%
Q3 2019$11,000
-45.0%
2,266
-22.7%
0.00%0.0%
Q2 2019$20,000
-51.2%
2,930
-46.2%
0.00%
-50.0%
Q1 2019$41,000
+720.0%
5,444
+818.0%
0.00%
Q4 2018$5,000
-37.5%
593
-44.7%
0.00%
-100.0%
Q1 2018$8,000
+60.0%
1,072
+37.8%
0.00%0.0%
Q4 2017$5,000778
+1044.1%
0.00%
Q2 2017$068
-32.0%
0.00%
Q1 2017$0
-100.0%
100
-93.1%
0.00%
-100.0%
Q4 2016$8,000
+700.0%
1,440
+1677.8%
0.00%
Q3 2016$1,000
-66.7%
81
-88.3%
0.00%
Q2 2016$3,000
-40.0%
694
-52.3%
0.00%
-100.0%
Q1 2016$5,000
-70.6%
1,455
-51.2%
0.00%
-66.7%
Q4 2015$17,000
+1600.0%
2,983
+1764.4%
0.00%
Q3 2015$1,0000.0%160
-20.4%
0.00%
Q2 2015$1,000
-85.7%
201
-59.8%
0.00%
-100.0%
Q1 2015$7,0005000.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Skylands Capital, LLC 1,772,000$13,379,0001.58%
Sargent Investment Group, LLC 856,315$6,465,0001.53%
Avenir Corp 1,366,549$10,317,0000.82%
CM Management, LLC 150,000$1,133,0000.82%
Winning Points Advisors, LLC 136,900$1,035,0000.78%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,397,0000.46%
SECTORAL ASSET MANAGEMENT INC 244,660$1,847,0000.15%
Redmile Group, LLC 1,304,369$9,848,0000.15%
Granahan Investment Management 1,003,546$7,577,0000.14%
ACT CAPITAL MANAGEMENT, LLC 35,000$265,0000.14%
View complete list of CYTOSORBENTS CORP shareholders